Enovis Share Price Today (NYSE: ENOV)

Name: Enovis Share Price (NYSE: ENOV) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Enovis share price is $31.9 & ₹2,745.47 as on 15 Jun 2025, 2.30 'hrs' IST

$31.9

▲

-0.39

(-1.21%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Enovis share price in Dollar and Rupees. Guide to invest in Enovis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Enovis, along with analyst recommendations, forecasts, and comprehensive financials.

Enovis share price movements

Today's Low: $31.50
Today's High: $32.44
$31.90
1.25%
Downside
Day's Volatility :2.9%
Upside
1.66%
52 Weeks Low: $29.13
52 Weeks High: $49.83
$31.90
8.7%
Downside
52 Weeks Volatility :41.55%
Upside
35.98%

Enovis (ENOV) Returns

Period	Enovis Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-18.68%	-6.1%	0.0%
6 Months	-30.4%	-3.4%	0.0%
1 Year	-29.18%	-6.7%	0.0%
3 Years	-44.24%	11.8%	2.2%

Enovis (ENOV) Key Statistics

in dollars & INR

Previous Close	$32.29
Open	$31.93
Today's High	$32.44
Today's Low	$31.5
Market Capitalization	$1.8B
Today's Volume	$1.4M
52 Week High	$49.83
52 Week Low	$29.125
Revenue TTM	$2.2B
EBITDA	$359.1M
Earnings Per Share (EPS)	$-14.64
Profit Margin	-37.65%
Quarterly Earnings Growth YOY	1.53%
Return On Equity TTM	-27.35%

How to invest in Enovis Stock (ENOV) from India?

It is very easy for Indian residents to invest directly in Enovis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enovis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enovis or ENOV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enovis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enovis shares which would translate to 0.027 fractional shares of Enovis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Enovis, in just a few clicks!

Returns in Enovis (ENOV) for Indian investors in Rupees

The Enovis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Enovis investment value today

Current value as on today

₹73,927

Returns

₹26,073

(-26.07%)

Returns from Enovis Stock

₹29,111 (-29.11%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Enovis (ENOV)

200%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Enovis Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Enovis

BlackRock Inc
12.54%
T. Rowe Price Investment Management,Inc.
10.87%
Vanguard Group Inc
10.69%
American Century Companies Inc
6.17%
Davenport & Company LLC
5.38%
Dimensional Fund Advisors, Inc.
5.12%

Analyst Recommendation on Enovis

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Enovis(by analysts ranked 0 to 5 stars)

Analyst Forecast on Enovis Stock (ENOV)

What analysts predicted

Upside of 77.12%

Target:

$56.50

Current:

$31.90

Insights on Enovis Stock (Ticker Symbol: ENOV)

Price Movement
In the last 1 month, ENOV stock has moved down by -10.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 560.97M → 558.83M (in $), with an average decrease of 0.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -703.33M → -55.96M (in $), with an average increase of 1156.7% per quarter
ENOV vs ABT (1 yr)
In the last 1 year, Abbott Laboratories has given 30.8% return, outperforming this stock by 59.7%
ENOV vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 29.4% return, outperforming this stock by 77.3%
Price to Sales
ForENOV every $1 of sales, investors are willing to pay $0.8, whereas for Abbott Laboratories, the investors are paying $5.6 for every $1 of sales.

Enovis Technicals Summary

Sell

Neutral

Buy

Enovis is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Enovis (ENOV) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Enovis Corp	-11.62%	-30.4%	-29.18%	-44.24%	8.07%
Medtronic Plc	0.95%	7.26%	9.14%	-0.16%	-8.68%
Edwards Lifesciences Corp.	-3.67%	1.66%	-13.5%	-14.35%	7.02%
Boston Scientific Corp.	-6.01%	10.18%	30.81%	180.67%	171.57%
Stryker Corporation	-4.3%	1.22%	9.44%	92.77%	97.03%
Abbott Laboratories	0.61%	20.42%	31.1%	32.87%	51.13%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Enovis Corp	15.87	NA	1.9	3.03	-0.27	0.01	NA	45.83
Medtronic Plc	24.39	24.39	2.51	5.46	0.1	0.05	0.03	37.46
Edwards Lifesciences Corp.	31.05	31.05	4.23	2.47	0.17	0.08	NA	17.28
Boston Scientific Corp.	72.55	72.55	2.46	2.92	0.1	0.05	NA	15.02
Stryker Corporation	52.06	52.06	2.23	13.34	0.14	0.07	0.01	54.77
Abbott Laboratories	17.61	17.61	4.17	5.16	0.31	0.06	0.02	28.06

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Enovis Corp	Buy	$1.8B	8.07%	15.87	-37.65%
Medtronic Plc	Buy	$112.9B	-8.68%	24.39	13.9%
Edwards Lifesciences Corp.	Buy	$44.1B	7.02%	31.05	75.71%
Boston Scientific Corp.	Buy	$147.1B	171.57%	72.55	11.58%
Stryker Corporation	Buy	$145.6B	97.03%	52.06	12.31%
Abbott Laboratories	Buy	$236.0B	51.13%	17.61	31.89%

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

Organization	Enovis
Employees	7367
CEO	Mr. Damien McDonald
Industry	Capital Goods

Management People of Enovis

Name	Title
Mr. Phillip Benjamin Berry	Senior VP & CFO
Mr. Bradley J. Tandy J.D.	Senior VP & Chief Legal Officer
Ms. Patricia A. Lang	Senior VP & Chief Human Resources Officer
Mr. Daniel A. Pryor	Executive Vice President of Strategy & Business Development
Mr. Damien McDonald	CEO & Director
Mr. John Kleckner	VP, Controller & Chief Accounting Officer
Mr. Kyle William Rose	Vice President of Investor Relations
Katie Sweet	Vice President of Corporate Communication
Mr. Tim Czartoski	President of U.S. Surgical and Global Product & Enabling Technologies
Mr. Davide Visentin	President of Enovis International Surgical

Important FAQs about investing in ENOV Stock from India :

Can Indians buy Enovis shares?

Yes, Indians can invest in the Enovis (ENOV) from India.

With INDmoney, you can buy Enovis at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Enovis at zero transaction cost.

How can I buy Enovis shares from India?

It is very easy to buy Enovis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enovis (ENOV) be purchased?

Yes, you can buy fractional shares of Enovis with INDmoney app.

What are the documents required to start investing in Enovis stocks?

To start investing in Enovis, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Enovis share price today?

Enovis share price today stands at $31.90, Open: $31.93 ; Previous Close: $32.29 ; High: $32.44 ; Low: $31.50 ; 52 Week High: $49.83 ; 52 Week Low: $29.13.

The stock opens at $31.93, after a closing price of $32.29. The stock reached a daily high of $32.44 and a low of $31.50, with a 52-week high of $49.83 and a 52-week low of $29.13.